Aim: The optimal management for early recurrent prostate cancer following radical prostatectomy (RP) in patients with negative prostate-specific membrane antigen positron-emission tomography (PSMA-PET) scan is an ongoing subject of debate. The aim of this study was to evaluate the outcome of salvage...
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate ... I Rauscher,T Maurer,WP Fendler,... - 《Cancer ...
PSMA PET/CT in comparison to mpMRI in ITM detection, although both imaging modalities provide complementary information. Furthermore, an in silico planning study from our group calculated significant higher tumor control probabilities when combined PSMA PET/CT and mpMRI information was considered for ...
(≤3 lesions), PSMA-positive disease underwent PSMA-directed treatments: salvage radiotherapy (sRT) or Metastases-directed therapy (MDT). Patients with polirecurrent (>3 lesions) PSMA-positive disease were treated with systemic therapy. Patients with negative PSMA-PET were treated with sRT or ...
UPDATE: Now Performing PSMA PET SCANS - Schedule with us today, The #1 HIGHEST Rated PET scan service provider nationwide.
– is a powerful predictor of increased nodal, metastatic and any upstaging in men with newly diagnosed high-risk prostate cancer. Patients with PPC greater than 50% and a Gleason score of 9 or 10 (Gleason grade group 5) are the most likely to benefit from getting the PSMA PET ...
Ga-prostate-specific membrane antigen (PSMA) PET/CT scan for primary staging discovered increased Ga-PSMA uptake in a known anal fistula in a recently diagnosed high-risk prostate cancer patient. The patient had an ongoing history of surgical revisions of complex fistulas in the perianal region, ...
For prostate cancer patients who experience biochemical progression during androgen deprivation therapy (ADT), prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has not been prospectively compared to planar
Approved PSMA-PET Imaging Tracer Options for Prostate Cancer Author(s): Phillip Koo, MD,Michael S. Cookson, MD, MMHC+2 More The panel reviews the similarities and differences between the FDA-approved PSMA-PET tracer options for prostate cancer imaging. EP: 1.Risk Stratification of Patients wit...
The results of summary evaluation for 68Ga-PSMA-PET/CT and bone scan in diagnosis of prostatic cancer as follow respectively: The SEN were 0.97 and 0.86; the SPE were 1.00 and 0.87; the DOR were 1468.33 and 36.23; PLR were 88.45 and 6.67; NLR were 0.05 and 0.19; and the area under ...